PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
07-Nov-2019 Urania Therapeutics closes a €3.5M initial seed round Advent France Biotechnology
07-Nov-2019 Freeline to present data on AAV-based gene therapies for Gaucher Disease and Haemophilia A at the 61st ASH Annual Meeting Freeline
07-Nov-2019 Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications Bavarian Nordic
07-Nov-2019 BERGENBIO’S BEMCENTINIB MEETS PRIMARY ENDPOINT IN FIRST COHORT OF PHASE 2 NSCLC STUDY IN COMBINATION WITH KEYTRUDA® BerGenBio
07-Nov-2019 Medigene AG: Medigene präsentiert Poster zu Neoantigenen als Zielmolekül für zellbasierte TCR-T-Therapien auf SITC-Jahrestagung 2019 Medigene AG
07-Nov-2019 Medigene AG: Immune monitoring data from phase I/II clinical trial with DC vaccines in AML to be presented at ASH conference Medigene AG
07-Nov-2019 Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 61st ASH Annual Meeting Autolus Therapeutics plc
07-Nov-2019 Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance Congress Summit Therapeutics plc
07-Nov-2019 BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine BC Platforms
07-Nov-2019 PredictImmune and the Crohn’s & Colitis Foundation announce start of jointly-sponsored study to validate PredictSURE IBD™, the first prognostic test for IBD, in the US market PredictImmune
07-Nov-2019 Hikma continues strong 2019 performance and reiterates full year guidance Hikma Pharmaceuticals PLC
07-Nov-2019 Immunomedics in software project with Ideagen to streamline document reviews of cancer treatment processes t reviews of cancer treatment processes Ideagen
06-Nov-2019 EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV ViiV Healthcare
06-Nov-2019 EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV ViiV Healthcare
06-Nov-2019 Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor Artios Pharma Limited
06-Nov-2019 Urania Therapeutics closes a €3.5M initial seed round Urania Therapeutics
06-Nov-2019 FLOURISH THROUGH THE MENOPAUSE Flourish
06-Nov-2019 Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia Autolus Therapeutics plc
06-Nov-2019 PureTech Affiliate Gelesis Presents Additional Data Highlighting Therapeutic Benefits of PlenityTM at ObesityWeek 2019 PureTech
05-Nov-2019 New EU mandate can provide relief for Europe’s most productivity-destroying disease Societal Impact of Pain